N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141635 |
| CAS No | NA |
| Mol.F. | C14H22N2O4 |
| Mol.Wt. | 282.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141636 |
| CAS No | NA |
| Mol.F. | C26H39N3O6 |
| Mol.Wt. | 489.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141637 |
| CAS No | NA |
| Mol.F. | C58H69F6N5O7 |
| Mol.Wt. | 1062.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141638 |
| CAS No | NA |
| Mol.F. | C29H34F3N3O4 |
| Mol.Wt. | 545.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141639 |
| CAS No | NA |
| Mol.F. | C12H19N3O3S |
| Mol.Wt. | 285.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141640 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141641 |
| CAS No | NA |
| Mol.F. | C16H20N2O3 |
| Mol.Wt. | 288.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141642 |
| CAS No | NA |
| Mol.F. | C12H19N5O4S |
| Mol.Wt. | 329.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141643 |
| CAS No | NA |
| Mol.F. | C22H16N8O2 |
| Mol.Wt. | 424.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141644 |
| CAS No | NA |
| Mol.F. | C21H20FN9O3 |
| Mol.Wt. | 465.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141645 |
| CAS No | NA |
| Mol.F. | C19H16FN9O3 |
| Mol.Wt. | 437.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141646 |
| CAS No | NA |
| Mol.F. | C44H70N2O14 |
| Mol.Wt. | 851.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141647 |
| CAS No | NA |
| Mol.F. | C22H20N4O6 |
| Mol.Wt. | 436.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141648 |
| CAS No | NA |
| Mol.F. | C20H17N3O5 |
| Mol.Wt. | 379.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141649 |
| CAS No | NA |
| Mol.F. | C22H19ClN4O5 |
| Mol.Wt. | 454.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141650 |
| CAS No | NA |
| Mol.F. | C21H18N4O5 |
| Mol.Wt. | 406.40 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |